BlackRock Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $207K | Hold |
43,605
| – | – | ﹤0.01% | 3200 |
|
|
2016
Q3 | $288K | Sell |
43,605
-103
| -0.2% | -$680 | ﹤0.01% | 3166 |
|
|
2016
Q2 | $239K | Buy |
43,708
+3,103
| +8% | +$17K | ﹤0.01% | 3246 |
|
|
2016
Q1 | $869K | Buy |
40,605
+863
| +2% | +$18.5K | ﹤0.01% | 2574 |
|
|
2015
Q4 | $1.26M | Buy |
39,742
+278
| +0.7% | +$8.79K | ﹤0.01% | 2432 |
|
|
2015
Q3 | $1.36M | Buy |
39,464
+4,473
| +13% | +$154K | ﹤0.01% | 2365 |
|
|
2015
Q2 | $1.1M | Buy |
34,991
+10,266
| +42% | +$323K | ﹤0.01% | 2691 |
|
|
2015
Q1 | $725K | Buy |
24,725
+4,216
| +21% | +$124K | ﹤0.01% | 2743 |
|
|
2014
Q4 | $380K | Buy |
20,509
+262
| +1% | +$4.85K | ﹤0.01% | 3111 |
|
|
2014
Q3 | $355K | Buy |
20,247
+332
| +2% | +$5.82K | ﹤0.01% | 3115 |
|
|
2014
Q2 | $398K | Buy |
+19,915
| New | +$398K | ﹤0.01% | 3118 |
|